|
HIV AND MORTALITY IN AFRICA
Does it prove
that HIV causes AIDS?
By Vladimir Koliadin
http://www.virusmyth.net/
August 1998
In a British-funded study, it was found that mortality in young (13-44)
adults in Uganda is 60 times higher for HIV-seropositives than for
seronegatives. Mainstream AIDS scientist present these results as a
strong evidence that HIV is the cause of AIDS. Such arguments are very
persuasive to public and most scientists, even though being essentially
flawed. Elementary analysis shows the results don't confirm, but refute
the official HIV-causes-AIDS hypothesis, and they are in good agreement
with predictions of the alternative hypotheses advanced by
"AIDS-dissidents".
1. Introduction
It is a frequent
situation in natural sciences when the same facts may be explained by
several competing hypotheses. Moreover, some facts may seem irrefutable
evidence for a hypothesis at first sight, but, after closer examination,
occur an evidence of the reverse. As far as scientific community and
public normally have some preconceived ideas (e.g. that HIV causes
AIDS), both easily accept such pseudo-evidences, and fail to notice the
obvious logical flaws. The stronger the collective belief in some idea,
the smaller the chance that the flaws in the "evidence" will be noticed.
Such situation makes it easy for wrong ideas to be widely accepted as
the ultimate truth, seemingly supported by a huge body of
incontrovertible evidence. In this paper, I am going to illustrate this
general point by an example from AIDS research. Results of a study
conducted in Uganda [1] are often referred to by mainstream AIDS
scientists as a strong evidence of the causal role of HIV in AIDS. Even
though this seems to be undoubtedly true at first sight, in reality, the
results are in serious contradiction with predictions of the official
HIV-causes-AIDS hypothesis, and confirm the alternative hypotheses which
assume that HIV is not a causal factor of AIDS. Unfortunately, the
obvious logical flaws in the "evidence" remained unnoticed by both
mainstream AIDS scientists and their opponents (at least I am not aware
about any publication which would have spotted the logical errors in the
seeming "evidence").
2. Some facts about
mortality and seroprevalence in Uganda
Results of the study
under investigation were described in [1]. Below, I cite from [2] only a
concise summary:
"In this study, a
rural population [in Uganda] of about 10,000 was screened for HIV
infection using highly specific tests. The seroprevalence of HIV
infection in those aged 13-44 was 9.6%. During follow up over two years,
eight deaths were obserevd in 5,800 man-years among seronegatives in
this age-group (1.4/1000 m-y), compared to 51 deaths in 534 man-years
among the seropositives (96/1000 m-y). The age adjusted rate ratio was
60 ...".
Thus, mortality was
more than 60 times higher among HIV-seropositives at age 13-44 than
among their HIV-negative counterparts. To interpret these results, it is
worth saying a few words about alternative hypotheses on nature of HIV-seropositivity
and to compare predictions of these hypotheses to that of the official
HIV-causes-AIDS theory.
3. Alternative
hypotheses on nature of HIV-seropositivity
There are several
hypotheses which explain the observed correlation between HIV-seropositivity
(a positive test for "HIV-antibodies") and severe opportunistic
AIDS-defining diseases. In spite of essential distinctions, all the
alternative hypotheses bear a common feature - HIV-seropositivity is
regarded as a consequence (marker) of low health status and diseases,
not as the cause.
First two hypotheses
hold that HIV-seropositivity is actually a consequence of HIV-infection,
but HIV is a benign retrovirus. In contrast to the official
HIV-causes-AIDS hypothesis, the two hypotheses regard HIV-infection as a
factor concomitant with diseases, but not their cause. Hypothesis I:
Correlation between HIV and AIDS is because HIV is only a marker of
specific unhealthy lifestyle typical to some segments of population -
promiscuous gays, drug users, etc. [3]. Hypothesis II: HIV is a harmless
ubiquitous retrovirus which is capable to replicate only if health is
already compromised. Thus, HIV-infection is a mild opportunistic
infection - an early indicator of some problems with immunity.
Other two hypotheses
hold that HIV does not exist at all as an exogenous transmissible agent.
The laboratory phenomena observed in cell cultures and interpreted by
the mainstream science as evidence of presence of HIV are explained by
mechanism which have nothing to do with a virus.
Hypothesis III: The
"HIV-proteins" do not belong to a virus, but are of intracellular
(endogenous) nature [4,5]. The genes which encode the structure of these
proteins are normally silent constituents of the human genome (most of
human genes are normally silent - that is, the proteins they encode are
not normally produced) [6]. Only under certain abnormal conditions, e.g.
in course of catabolic stress, the genes are switched on and the cells
start to produce these proteins. As far as the proteins are foreign for
the immune system, specific antibodies are produced against them. These
antibodies are detected by the HIV-antibody tests, and corresponding
messenger RNA are detected by the "viral load tests".
Hypothesis IV: The
antibodies to which the HIV-antibody tests react are not specific at all
- they belong to non-specific immunoglobulins. Under certain conditions
(e.g. overstimulation by foreign antigens, catabolic stress), B-cells
become hyperactive and produce immunoglobulins with higher non-specific
affinity than usually [6]. Both ELISA and Western Blot tests are
abnormally sensitive to non-specific binding because both are based on
"sandwich" principle [7]. Hence, a positive HIV-antibody test is only a
marker indicating that B-cells are hyperactive (which is a hallmark of
AIDS and many other abnormal states of organism).
Thus, there is no
shortage of alternative explanations of the HIV-seropositivity and its
association with severe diseases. Comparative analysis of the
alternative hypothesis lies beyond the scope of this paper. The only
thing which will be taken into account here is that all the alternative
hypotheses regard HIV-seropositivity as a marker of compromised health
or other disease-causing factors. Therefore, I will refer to all these
hypotheses as "marker hypotheses", for short.
4. Predictions of
the competing hypotheses
If HIV-seropositivity
is only marker of deteriorated health and diseases, HIV-seropositive
individuals will show significantly higher morbidity and mortality than
HIV-seronegative ones. The official HIV-causes AIDS hypothesis also
predicts higher mortality in the HIV-seropositive group. Hence, the fact
that mortality is much higher in seropositives than in seronegatives is
explainable by the official as well as by the alternative hypotheses,
and it cannot be an evidence that HIV causes AIDS. Is it possible to
discriminate between the official and the alternative "marker
hypotheses"? If to focus only at mortality in HIV-seropositive group, it
is hardly possible - all the hypotheses predict that mortality and
morbidity among HIV-seropositives will be higher than among HIV-seronegatives.
But it seems to have remained unnoticed by both mainstream AIDS
scientists and their opponents that analysis of mortality in
HIV-negatives can provide important clues [7]. If HIV is actually a new
pathogen and causes additional mortality independently on other causes
of death typical to this region (as the official theory holds),
mortality in HIV-negative population should be about the same as before
HIV-epidemic. Prediction of the "marker hypotheses" is radically
different - mortality in seronegatives has to be lower than the death
rate usual to this population. Actually, let HIV-seropositivity is only
an indicator of diseases and compromised health. Then, a great
proportion of the individuals who were to have died from causes usual to
this region and not related to HIV (mainly various infectious and
parsitic diseases) will fall into the HIV-seropositive group. Therefore,
the total number of deaths in the HIV-seronegative group will be lower
than that expected from usual rates of non-HIV-related mortality.
5. Comparing
predictions of the competing hypotheses to reality
Mortality in
HIV-negative group in the investigated population of Uganda was 1.38 per
1000 person-years (8 deaths in 5800 person-years of observation). Is it
reasonable to assume that this mortality rate is usual for a rural area
of Uganda? (The terms "usual mortality" or "usual deaths" means here the
deaths not related to HIV and expected from the death rates observed
earlier than the hypothetical HIV-epidemic began). Because any more or
less reliable statistical information is absent about the usual
mortality in Uganda, we will use indirect approach to answer this
question.
It is well known that
usual mortality among young adults in many African countries, including
Uganda, is much higher than that in developed countries - a great
proportion of population die young, mainly from various parasitic and
infectious diseases. This difference is explained by general poverty,
malnutrition, lack of adequate medical service typical to many African
countries. Is the annual mortality rate in 1.38/1000 observed in
HIV-negative Ugandans compatible with this general information? The
answer is definitely negative at least on two counts. First, rough
calculations show that such annual mortality rate is equivalent to 96%
survival in 30 years (only 4% die during 30 years, say from age 13 to
44). This is in obvious contradictions with the fact that a significant
proportion of the population die young. Second, mortality rate in
HIV-negative Ugandans at age 13-44 is even lower than mortality in the
USA observed in the pre-AIDS era: in 1980, 157,685 deaths were
registered in the USA at ages 15-44, and the population at this age was
105,203,377. This gives general mortality rate 1.5/1000 (higher than the
1.38/1000 in HIV-negative Ugandans). It is unreasonable to believe that
usual mortality in a rural population of Uganda is about the same as in
the USA - one of the most prosperous country all over the world. Hence,
the observed mortality in HIV-seronegative population of Uganda is
definitely much lower than the usual mortality rate typical to this
population. In other words, most of the Ugandans who were to have died
even without the hypothetical HIV epidemic, occurred to be HIV-seropositive
when tested for "HIV-antibodies". This means that either HIV (if it
really exists) "prefers" the individuals with compromised health and at
high risk of diseases typical to this region, or that HIV-seropositivity
is a biochemical marker of compromised health and these diseases.
6. Quantitative
analysis
How much reality
departs from predictions of the official HIV-causes-AIDS hypothesis? Let
us make some quantitative estimates. We assume first that HIV is
actually a new deadly pathogen and it infects individuals irrespective
to their health status - that is the HIV-causes-AIDS theory is correct.
In this case, the "usual" deaths (not related to HIV) will be
distributed between HIV-positive and HIV-negative groups in the same
proportion as the sizes of these groups, and mortality in the
HIV-negative group would be equal to the "usual" mortality - because
HIV-related deaths, even if they are real, would fall into the
HIV-positive group. Let, for example, usual annual mortality is 3/1000
(that is about 2.2 times higher than mortality observed in HIV-seronegative
Ugandans). The average expected number of "usual" deaths would be 1.6
(=534*0.003) in the HIV-positive group (534 person-years), and 17.4
(=5800*0.003) in the HIV-negative group (5800 person-years). Expected
ratio is 0.092 (=1.6/17.4). The actual (observed) number of deaths in
HIV-negative group is only 8. Hence, the remaining 9.4 (=17.4-8) deaths
expected for "usual" mortality fell into the HIV-positive group, and the
total number of "usual" deaths in this group is 11 (=1.6+9.4). Thus, the
actual distribution of "usual" deaths between HIV-positive and
HIV-negative groups is 11 against 8. The ratio of these numbers (1.375)
is 15 times higher than that expected for HIV-causes-AIDS hypothesis
(0.092). (It may seem strange at first sight that, if "usual" mortality
is only 2.2 times higher than the observed mortality in the HIV-negative
group, the ratio between observed and expected proportions is so high as
15. But it is a natural consequence of the fact that size of the
HIV-positive group is more than 10 times smaller than the size of the
HIV-negative one.)
As far as precise value
for "usual" mortality in this region of Uganda is not known,
computations were carried out for several values of the "usual"
mortality. The results are summarized in the table. Column 2 shows
probability of survival in 30 years - it helps to decide whether the
"usual" mortality rate in column 1 is compatible with the qualitative
information that a great proportion of population die young. The ratio
between expected and actual proportions (computed as described above) is
shown in column 3.
----------------------------------------------------------------
"Usual" mortality Survival in 30 years Ratio of proportions
(1/1000 peson-years) (percent) (observed/expected)
----------------------------------------------------------------
1.38 95.9 1.0
3.0 91.4 14.9
5.0 86.0 32.1
7.0 81.0 49.3
9.3 75.6 69.1
----------------------------------------------------------------
It is reasonable to
assume that usual mortality rate in young adults in Uganda is at least
several times higher than in the USA (1.5/1000). If the usual mortality
in Uganda is, say 5/1000 person-years, the observed distribution of
usual deaths between seropositive and seronegative groups differs 32
times from that expected for the HIV-causes-AIDS hypothesis (see table).
There are also no any serious reasons to believe that the observed
annual rate of overall mortality among HIV-negatives and HIV-positives
combined (9.3/1000 person-years) differs from the usual death rate for
this population. At least 75% survival in 30 years is quite compatible
with the qualitative information that significant proportion of the
local population die young. In this case, we might conclude that
association between HIV-seropositivity and usual mortality is 69 times
higher than that expected from the predictions of the HIV-causes-AIDS
theory.
7. Can we trust the
mainstream AIDS science?
The elementary analysis
described above easily revealed strong inconsistencies between
predictions of the official HIV-causes-AIDS theory and real facts, and
showed that the facts are in good agreement with predictions of the
alternative "marker hypotheses". Nevertheless, mainstream AIDS
scientists ignore these obvious inconsistencies and present results of
the study [1] as a strong evidence of the HIV-causes-AIDS theory. For
some reasons, scientific community and public have proven to be
incapable to analyze such pseudo-evidences more or less critically -
they readily accepted them as true evidences of the official theory.
This lack of critical thinking is a bad symptom - it is a sign that
scientific enterprise lost its ability to judge facts objectively and
independently on collective beliefs. This raises a more general
question: To which extent the various experimental and observational
"evidences" of the HIV-causes-AIDS theory published by mainstream AIDS
scientists are true evidences? Critical and independent reevaluation of
such "evidences" is urgently needed, at least as far as we wish to
arrive at more or less objective picture of reality and to establish
actual causes of AIDS and ways to treat and prevent this disease.
Conclusions
The observed death rate
in HIV-seronegative Ugandans (1.38/1000 person years) is definitely
lower than the usual (not related to HIV) death rate typical to this
region. This is in perfect agreement with predictions of the alternative
hypotheses which regard HIV-seropositivity as only a marker of
deteriorated health and diseases usual to this region; and this
contradicts to predictions of the official HIV-causes-AIDS theory.
Quantitative estimates show that actual distribution of "usual" deaths
between HIV-seropositive and seronegative population differs from that
predicted by the HIV-causes-AIDS theory 30-70 times. Nevertheless,
mainstream AIDS science presents the results as a strong evidence of the
HIV-causes-AIDS theory, and the rest of scientific community and public
gullibly accepts them as such.
References
1. Mulder, D.W., Nunn, A.J., Kamali, A.
et al. Two-year HIV-1-associated mortality in a Ugandan rural
population. Lancet v.343, pp. 1021-1023 (April 23, 1994)
2. Robinson, J. and Hayes, R. The other
side. RSS News v.22, no 10, p.13 (1994)
3. Duesberg,P.H. AIDS acquired by drug
consumption and other noncontagious risk factors. Pharmac.Ther.
v.55, pp.201-277, 1992
4. Papadopulos-Eleopulos, E., Turner,
V.F, Papadimitriou, J.M. Is a positive Western Blot proof of HIV
infection? Bio/Technology v.11, pp.697-707, June 1993
5. Papadopulos-Eleopulos,E., Turner, V.F,
Papadimitriou, J.M., Causer, D. The isolation of HIV: Has it really been
achieved? The case against. Continuum (supplement) v.4, no.3,
pp.1-24, September/October 1996
6. Koliadin, V.L. Critical analysis of
the current views on the nature of AIDS. Genetica v.95, pp.71-90,
January/March 1995
7. Koliadin, V.L. What causes a positive
test for HIV antibodies. In "UN-Public Information Dossier, 2nd Edition"
(IFAS - International Forum for Accessible Science), pp. 48-55, April
1998.
|